Multicenter, randomized, double-blind, placebo-controlled, single-ascending dose study of the oral γ-secretase inhibitor BMS-708163 (Avagacestat): tolerability profile, pharmacokinetic parameters, and pharmacodynamic markers (Q83550720)
Jump to navigation
Jump to search
scientific article published on 28 February 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Multicenter, randomized, double-blind, placebo-controlled, single-ascending dose study of the oral γ-secretase inhibitor BMS-708163 (Avagacestat): tolerability profile, pharmacokinetic parameters, and pharmacodynamic markers |
scientific article published on 28 February 2012 |
Statements
Multicenter, randomized, double-blind, placebo-controlled, single-ascending dose study of the oral γ-secretase inhibitor BMS-708163 (Avagacestat): tolerability profile, pharmacokinetic parameters, and pharmacodynamic markers (English)
Gary Tong
Jun-Sheng Wang
Oleksandr Sverdlov
Shu-Pang Huang
Randy Slemmon
Robert Croop
Lorna Castaneda
Huidong Gu
Oi Wong
Hewei Li
Robert M Berman
Christina Smith
Charles F Albright
Randy C Dockens
28 February 2012